Introduction: This study reports a case of bevacizumab administered to treat choroidal neovascularisation in a woman later discovered to be pregnant.
Clinical picture: A 25-year-old pregnant woman developed myopic choroidal neovascularisation in both eyes.
Treatment: Both eyes were treated with a total of 3 intravitreal injections of bevacizumab sequentially.
Outcome: Vision improved significantly in both eyes. There were no evident pregnancy-related complications at 1 year postpartum.
Conclusion: Although anti-vascular endothelial growth factor (VEGF) therapy did not result in any detectable short-term adverse event in this mother and baby, the potential toxicity of these agents must be carefully considered in pregnant patients.